Epizyme Inc EPZM:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
5.33UNCH (UNCH)
Volume
7,291
Close
5.33quote price arrow down-0.14 (-2.56%)
Volume
469,720
52 week range
4.72 - 14.30
Loading...
  • Open5.46
  • Day High5.50
  • Day Low5.30
  • Prev Close5.47
  • 52 Week High14.30
  • 52 Week High Date12/01/20
  • 52 Week Low4.72
  • 52 Week Low Date08/20/21

Key Stats

  • Market Cap544.99M
  • Shares Out102.25M
  • 10 Day Average Volume0.86M
  • Dividend-
  • Dividend Yield-
  • Beta1.17
  • YTD % Change-50.92

KEY STATS

  • Open5.46
  • Day High5.50
  • Day Low5.30
  • Prev Close5.47
  • 52 Week High14.30
  • 52 Week High Date12/01/20
  • 52 Week Low4.72
  • 52 Week Low Date08/20/21
  • Market Cap544.99M
  • Shares Out102.25M
  • 10 Day Average Volume0.86M
  • Dividend-
  • Dividend Yield-
  • Beta1.17
  • YTD % Change-50.92

RATIOS/PROFITABILITY

  • EPS (TTM)-2.53
  • P/E (TTM)-2.11
  • Fwd P/E (NTM)-2.92
  • EBITDA (MRQ)-229.851M
  • ROE (MRQ)-177.98%
  • Revenue (MRQ)32.58M
  • Gross Margin (MRQ)73.06%
  • Net Margin (MRQ)-788.60%
  • Debt To Equity (MRQ)341.86%

EVENTS

  • Earnings Date11/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Epizyme Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Epizyme, Inc. is a clinical-stage biopharmaceutical company. The Company discovers, develops and plans to commercialize epigenetic therapies for cancer patients. The Company is engaged in the discovery and development of novel epigenetic therapies for cancer patients. The Company develops small molecule inhibitors of a class of enzymes known as histone methyltransferases (HMTs). The Company develops small molecule inhibitors of other chromatin modifying proteins (CMPs). The...
David Mott
Non-Executive Chairman
Grant Bogle
President
Matthew Ros
Chief Financial Officer
Shefali Agarwal M.D.
Executive Vice President
Address
400 Technology Sq Ste 4
Cambridge, MA
02139-3584
United States

Top Peers

SYMBOLLASTCHG%CHG
MCRB
Seres Therapeutics Inc
6.94-0.15-2.12%
FIXX
Homology Medicines Inc
8.64-0.07-0.80%
GRTS
Gritstone bio Inc
11.35-0.46-3.89%
MGTX
MeiraGTx Holdings PLC
13.37-0.21-1.55%
SPRO
Spero Therapeutics Inc
18.73-0.78-4.00%